Back
Also listed as
DGWPF
OTC
Day Range
$109.51
$109.51
52-Week Range
$58.15
$111.00
Volume
100
50D / 200D Avg
$99.68
/
$81.59
Prev Close
$104.99
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 16.5 | 0.4 |
| P/B | 1.3 | 2.9 |
| ROE % | 8.5 | 3.7 |
| Net Margin % | 3.7 | 3.9 |
| Rev Growth 5Y % | -0.3 | 10.0 |
| D/E | 0.3 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$10.78
$10.45 – $11.47
|
3.9 B | 1 |
| FY2028 |
$10.18
$9.87 – $10.83
|
3.8 B | 1 |
| FY2027 |
$8.64
$8.37 – $9.18
|
3.7 B | 1 |
Key Takeaways
Revenue declined -0.26% annually over 5 years
Debt/Equity of 0.26 — conservative balance sheet
Generating 103.52M in free cash flow
PEG of 0.55 suggests growth is underpriced
Cash machine — converts 83.21% of earnings into free cash flow
Capital efficient — spends only 1.89% of revenue on capex
Growth
Revenue Growth (5Y)
-0.26%
Revenue (1Y)-0.08%
Earnings (1Y)12.65%
FCF Growth (3Y)N/A
Quality
Return on Equity
8.46%
ROIC6.99%
Net Margin3.69%
Op. Margin5.34%
Safety
Debt / Equity
0.26
Current Ratio1.93
Interest Coverage6.65
Valuation
P/E Ratio
16.51
P/B Ratio1.34
EV/EBITDA12.37
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.08% | Revenue Growth (3Y) | 5.21% |
| Earnings Growth (1Y) | 12.65% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0.26% | Earnings Growth (5Y) | -16.02% |
| Profitability | |||
| Revenue (TTM) | 3.37B | Net Income (TTM) | 124.41M |
| ROE | 8.46% | ROA | 4.02% |
| Gross Margin | 44.87% | Operating Margin | 5.34% |
| Net Margin | 3.69% | Free Cash Flow (TTM) | 103.52M |
| ROIC | 6.99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.26 | Current Ratio | 1.93 |
| Interest Coverage | 6.65 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 16.51 | P/B Ratio | 1.34 |
| P/S Ratio | 0.61 | PEG Ratio | 0.55 |
| EV/EBITDA | 12.37 | Dividend Yield | 0.04% |
| Market Cap | 2.05B | Enterprise Value | 2.23B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 3.37B | 3.37B | 3.05B | 3.33B | 3.41B |
| Net Income | 124.41M | 110.43M | -64.56M | 154.23M | 250.16M |
| EPS (Diluted) | 6.61 | 5.89 | -3.44 | 7.16 | 10.22 |
| Gross Profit | 1.51B | 1.46B | 1.24B | 1.54B | 1.61B |
| Operating Income | 180.01M | 184.13M | -79.76M | 277.68M | 411.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 3.09B | 3.09B | 3.11B | 3.18B | 3.31B |
| Total Liabilities | 1.56B | 1.69B | 1.79B | 1.92B | 2.27B |
| Shareholders' Equity | 1.54B | 1.41B | 1.32B | 1.26B | 1.03B |
| Total Debt | 395.58M | 471.38M | 361.95M | 348.01M | 370.75M |
| Cash & Equivalents | 223.47M | 260.00M | 302.47M | 439.44M | 492.23M |
| Current Assets | 1.88B | 1.87B | 1.90B | 1.99B | 2.15B |
| Current Liabilities | 978.48M | 1.02B | 1.22B | 934.91M | 1.15B |